FOXO3 and pancreatic neoplasm: Recently, it has been showed that EGCG inhibits pancreatic cancer orthotopic tumor growth, angiogenesis and metastasis associated with inhibition of ERK and PI3K/AKT pathways and activation of FKHRL1/FOXO3a [18].